ICER’s 2023 report highlights five drugs with unsupported price increases, leading to $815 million in excess costs for U.S. payers. Discover key findings and trends.
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Where Today's News Shapes Tomorrow
